Abalone Bio
PrivateLast Round
Grant
Apr 1, 2024
Total Funding Raised
$11.07M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Abalone Bio is a biotechnology company that develops activating antibody-based therapeutics for challenging diseases, including cancer, pain, inflammatory conditions, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abalone Bio Comparables
Compare Abalone Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InterAx Biotech | 79% | |
| Octant | 79% | |
| Infinimmune | 78% |
Abalone Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2024 | ||||
| Grant | Sep 12, 2022 | ||||
| Grant | Aug 1, 2022 | ||||
| Grant | Aug 19, 2021 | ||||
| Grant | May 1, 2021 | ||||
Grant | Feb 1, 2021 |
Abalone Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Y Combinator | Seed, Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 94% MoM.
- Mar 11, 2025
Partnering with the University of Pennsylvania to develop obesity drugs.
Abalone Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abalone Bio's valuation, stock price, and market status.
Is Abalone Bio a public or private company?
Abalone Bio is a private company.
What is the current stock price of Abalone Bio?
Abalone Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Abalone Bio worth (valuation)?
Valuation information for Abalone Bio is not publicly available.
Can I buy Abalone Bio stock?
Abalone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Abalone Bio's last funding round?
Abalone Bio's most recent funding round was Grant on April 1, 2024.
Who are the main investors in Abalone Bio?
Key investors in Abalone Bio include Y Combinator.
Will Abalone Bio IPO soon?
No public IPO plans have been announced for Abalone Bio.
How can I track Abalone Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abalone Bio's secondary market activity and sign up for updates.